| |
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
 |
| |
|
| 제 목 |
fmJLwpYKwwQcnDVnIBr |
|
| 이 름 |
Chester |
날 짜 |
2018/06/28 |
조 회 |
1 |
|
Please call back later wake up lean amazon Among those who received Gilotrif, progression-free survival was 4.2 months longer than those who received chemotherapy, the FDA said. There was no statistically significant difference in overall survival, the agency added.
|
|
|
 |
|
| |
|
|
|
| |
|
|
|
|
|
| |
|
|
|
